Cargando…
Outcomes in patients managed with endovascular stent for malignant superior vena cava syndrome
BACKGROUND: Malignant Superior Vena Cava Syndrome (SVCS) corresponds to the clinical manifestations due to the restriction of venous return to the right atrium secondary to obstruction of the superior vena cava and/or its main tributaries for a tumor. Endovascular management has proven to be safe, e...
Autores principales: | Guerrero-Macías, S., Beltrán, J., Buitrago, R., Beltrán, R., Carreño, J., Carvajal-Fierro, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517271/ https://www.ncbi.nlm.nih.gov/pubmed/37744312 http://dx.doi.org/10.1016/j.sopen.2023.09.001 |
Ejemplares similares
-
Endovascular stenting in malignant obstruction of superior vena cava
por: Hamzik, Julian, et al.
Publicado: (2015) -
Superior vena cava syndrome: endovascular management
por: Karakhanian, Walter Kegham, et al.
Publicado: (2019) -
Endovascular stenting for malignant superior vena cava syndrome - Case series and review of literature
por: Arshad, Abdul Majeed, et al.
Publicado: (2023) -
Endovascular Stenting as a First Choice for the Palliation of Superior Vena Cava Syndrome
por: Kim, Yu-Il, et al.
Publicado: (2004) -
Percutaneous stenting of malignant superior vena cava syndrome in a patient with persistent left and absent right superior vena cava
por: Chen, Fang, et al.
Publicado: (2019)